Articles in this Issue
Many early adopters of rapid methods later went back to traditional methods. What were these technologies and when did early adopters continue using them?
In biopharmaceutical development, product quality is the highest priority. The resulting structure must be exactly as designed and of exceptional purity.
The “holy grail” of patient-centricity is the transition from injectables to oral dosages, a move that drastically patient compliance and quality of life.
When properly integrated through appropriate design planning, validation and alignment with regulatory expectations, continuous monitoring can strengthen contamination control strategies and support the consistent production of safe sterile medicines.